GSK plc (LON:GSK) Receives GBX 1,805.83 Consensus Target Price from Analysts

Shares of GSK plc (LON:GSK) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is GBX 1,805.83 ($22.70).

A number of research firms have issued reports on GSK. Shore Capital restated a “buy” rating on shares of GSK in a report on Wednesday, August 28th. Berenberg Bank dropped their price target on GSK from GBX 1,820 ($22.88) to GBX 1,600 ($20.11) and set a “buy” rating on the stock in a research report on Friday, November 29th. JPMorgan Chase & Co. reissued an “underweight” rating on shares of GSK in a research report on Wednesday, December 11th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,850 ($23.25) target price on shares of GSK in a research report on Tuesday, September 3rd.

GSK Trading Down 1.0 %

LON:GSK opened at GBX 1,308.50 ($16.45) on Friday. The company has a debt-to-equity ratio of 123.04, a quick ratio of 0.73 and a current ratio of 0.82. The company has a market capitalization of £53.39 billion, a P/E ratio of 1,157.96, a P/E/G ratio of 1.24 and a beta of 0.31. The stock’s 50 day moving average price is GBX 1,387.25 and its 200 day moving average price is GBX 1,507.27. GSK has a 52 week low of GBX 1,282.50 ($16.12) and a 52 week high of GBX 1,823.50 ($22.92).

GSK Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, November 14th will be paid a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a yield of 1.03%. GSK’s payout ratio is 5,309.73%.

Insider Activity at GSK

In other news, insider Jonathan Symonds purchased 7,150 shares of GSK stock in a transaction on Wednesday, October 30th. The stock was purchased at an average price of GBX 1,394 ($17.52) per share, with a total value of £99,671 ($125,277.78). 1.61% of the stock is owned by insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.